3 Reasons Viking Therapeutics Stock Could 10X if Its Obesity Pipeline Succeeds

Viking stock has plenty of room to run.The weight loss drug market has been one key focus for investors in recent years. This is because demand has been incredibly high, driving blockbuster revenue for companies making such products -- here, I'm talking about pharma giants Eli Lilly and Novo Nordisk.But these companies aren't the only ones that could win in the market in the years to come. One biotech company in particular is approaching the finish line, with its candidate involved in a phase 3 trial. This ...